Trials / Completed
CompletedNCT01787188
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy, and Safety Study of Meloxicam SoluMatrix™ Capsules in Patients With Pain Due to Osteoarthritis of the Knee or Hip
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 403 (actual)
- Sponsor
- Iroko Pharmaceuticals, LLC · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Meloxicam \[Test\] Capsules are safe and effective for the treatment of osteoarthritis pain of the knee or hip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meloxicam Test Capsules | |
| DRUG | Meloxicam Test Capsules | |
| DRUG | Placebo Capsules |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-02-08
- Last updated
- 2015-03-11
- Results posted
- 2015-03-11
Locations
40 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01787188. Inclusion in this directory is not an endorsement.